DexCom, Inc. (FRA:DC4)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of EUR 23.87 billion. The enterprise value is 23.36 billion.

Market Cap	23.87B
Enterprise Value	23.36B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	384.86M
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.09%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	97.07%
Float	383.05M

Valuation Ratios

The trailing PE ratio is 33.52 and the forward PE ratio is 28.67.

PE Ratio	33.52
Forward PE	28.67
PS Ratio	6.01
PB Ratio	10.21
P/TBV Ratio	10.57
P/FCF Ratio	26.02
P/OCF Ratio	19.46
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.96, with an EV/FCF ratio of 25.46.

EV / Earnings	32.80
EV / Sales	5.90
EV / EBITDA	22.96
EV / EBIT	30.19
EV / FCF	25.46

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio	1.88
Quick Ratio	1.53
Debt / Equity	0.51
Debt / EBITDA	1.17
Debt / FCF	1.30
Interest Coverage	49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE)	34.50%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	33.98%
Return on Capital Employed (ROCE)	21.72%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	359,333
Profits Per Employee	64,459
Employee Count	11,050
Asset Turnover	0.73
Inventory Turnover	3.18

Taxes

In the past 12 months, DexCom has paid 214.71 million in taxes.

Income Tax	214.71M
Effective Tax Rate	23.16%

Stock Price Statistics

The stock price has decreased by -28.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.39%
50-Day Moving Average	59.01
200-Day Moving Average	63.59
Relative Strength Index (RSI)	59.21
Average Volume (20 Days)	187

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.92

Income Statement

In the last 12 months, DexCom had revenue of EUR 3.97 billion and earned 712.28 million in profits. Earnings per share was 1.78.

Revenue	3.97B
Gross Profit	2.39B
Operating Income	776.58M
Pretax Income	926.99M
Net Income	712.28M
EBITDA	991.04M
EBIT	776.58M
Earnings Per Share (EPS)	1.78

Balance Sheet

The company has 1.70 billion in cash and 1.19 billion in debt, with a net cash position of 512.98 million.

Cash & Cash Equivalents	1.70B
Total Debt	1.19B
Net Cash	512.98M
Net Cash Per Share	n/a
Equity (Book Value)	2.34B
Book Value Per Share	6.08
Working Capital	1.61B

Cash Flow

In the last 12 months, operating cash flow was 1.23 billion and capital expenditures -309.59 million, giving a free cash flow of 917.45 million.

Operating Cash Flow	1.23B
Capital Expenditures	-309.59M
Free Cash Flow	917.45M
FCF Per Share	n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin	60.10%
Operating Margin	19.56%
Pretax Margin	23.35%
Profit Margin	17.94%
EBITDA Margin	24.96%
EBIT Margin	19.56%
FCF Margin	23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.75%
Shareholder Yield	1.75%
Earnings Yield	2.98%
FCF Yield	3.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score	7.06
Piotroski F-Score	6